Sabra Healthcare REIT Inc [SBRA] stock is trading at $17.77, up 0.79%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SBRA shares have gain 2.01% over the last week, with a monthly amount drifted -0.67%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sabra Healthcare REIT Inc [NASDAQ: SBRA] stock has seen the most recent analyst activity on January 17, 2025, when Truist downgraded its rating to a Hold. Previously, JMP Securities upgraded its rating to Mkt Outperform on January 07, 2025, and kept the price target unchanged to $20. On December 05, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $20 on the stock. Wells Fargo upgraded its rating to a Overweight and increased its price target to $20 on October 01, 2024. Citigroup upgraded its rating to a Buy and raised its price target to $20 on September 13, 2024. Deutsche Bank started tracking with a Buy rating for this stock on January 30, 2024, and assigned it a price target of $21. In a note dated October 17, 2023, BMO Capital Markets downgraded an Market Perform rating on this stock but restated the target price of $16.
Sabra Healthcare REIT Inc [SBRA] stock has fluctuated between $13.81 and $19.99 over the past year. Currently, Wall Street analysts expect the stock to reach $17.29 within the next 12 months. Sabra Healthcare REIT Inc [NASDAQ: SBRA] shares were valued at $17.77 at the most recent close of the market. An investor can expect a potential drop of -2.7% based on the average SBRA price forecast.
Analyzing the SBRA fundamentals
Sabra Healthcare REIT Inc [NASDAQ:SBRA] reported sales of 714.38M for the trailing twelve months, which represents a growth of 7.74%. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at 0.52%, Pretax Profit Margin comes in at 0.2%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.05 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.51 points at the first support level, and at 17.25 for the second support level. However, for the 1st resistance point, the stock is sitting at 17.96, and for the 2nd resistance point, it is at 18.15.
Ratios To Look Out For
For context, Sabra Healthcare REIT Inc’s Current Ratio is 0.25. In addition, the Quick Ratio stands at 0.25 and the Cash Ratio stands at 0.01. Considering the valuation of this stock, the price to sales ratio is 5.92, the price to book ratio is 1.56 and price to earnings (TTM) ratio is 30.08.
Transactions by insiders
Recent insider trading involved FOSTER MICHAEL J, Director, that happened on May 20 ’25 when 11000.0 shares were sold. Director, Michael J. Foster completed a deal on May 15 ’25 to buy 11000.0 shares. Meanwhile, Director Cusack Catherine bought 1500.0 shares on Feb 24 ’25.
